Daniel M. Junius
At a glance: Daniel M. Junius is Director at Idexx Laboratories (IDXX). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $494K. On file: 0 purchase lines ($0) and 2 sale lines ($845K).
Disclosed holdings: about $1.6M of IDXX stock: 2,361 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 19, 2026 close of $690.95. This counts only IDXX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Idexx Laboratories Inc /De (IDXX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Daniel M. Junius's InsiderPrint
5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $68K a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Paola M. ArbourDirector · TCBI · 100% match
- Garen G. BohlinDirector · COLL · 99% match
- Daniel G. KayeDirector · CME · 99% match
- Justin ScarpullaSvp, Chief Accounting Officer · MRVL · 99% match
- Tiffany Thom CepakDirector · PTEN · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Daniel M. Junius
Get one email when Daniel M. Junius files a new purchase or sale. Free.
At most one email a day about Daniel M. Junius, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.